Fundraising FoxSanten Pharmaceutical
Corporate VCOsaka · Series A–Series C · 24 people tracked
Find your way into Santen Pharmaceutical
Sign up to see every warm intro you have to Santen Pharmaceutical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Santen Pharmaceutical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Santen Pharmaceutical is an Osaka, Japan-based pharmaceutical company specializing in ophthalmology, with operations in about 20 countries and products sold in more than 70. Alongside its core research, development, and commercialization business, it has made corporate venture investments in health-related startups across Series A through Series C rounds.
Source: firm website, verified Sep 27, 2026.
Team · 24 people
from the firm's website
What they invest in
from 1 of 2 portfolio companiesBiotech ×1
HQs:United States×1
Investments · 2 tracked
founders shown can be your intro pathOther
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
International BioMedical DevicesRetroSense Therapeutics
Exits · 1
1 acquisitionsRetroSense Therapeuticsacq. by Allergan
Frequently asked questions
- What stage does Santen Pharmaceutical invest at?
- Santen Pharmaceutical invests at the Series A, Series B, Series C stages.
- What sectors does Santen Pharmaceutical focus on?
- Santen Pharmaceutical focuses on Biotech, Healthtech, Medical Devices.
- Where is Santen Pharmaceutical located?
- Santen Pharmaceutical is headquartered in Osaka, JP.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
OneVentures is a later-stage venture capital firm that backs technology and healthcare companies, providing growth equity and credit alongside strategic and operational support.
Avego is a healthcare-focused investment firm that partners with entrepreneurs and management teams across private and public companies developing products and services throughout the healthcare continuum. Its Avego BioScience Capital strategy focuses on mid-to-late stage venture financings for biotech companies.
Roadmap Capital is a Toronto-based investment firm focused on Deep Tech, backing tangible engineering innovations with high barriers-to-entry and strong intellectual property portfolios across ICT, sensors and actuators, and medical devices.